The Group's principal activities are establishing and coordinating business strategies for Green Cross subsidiaries, launching new strategic businesses, and managing investment portfolios. Its product includes pharmaceutical products such as Blood Derivatives, Vaccines, Diagnostic Reagents, Prescription Drugs and over the counter Drugs.
Alacra Alerts:
Receive alerts on the latest reports on Korea Green Cross Corporation
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
